Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing
Fibrotic diseases contribute to 45% of deaths in the industrialized world, and therefore a better understanding of the pathophysiological mechanisms underlying tissue fibrosis is sorely needed. We aimed to identify novel modifiers of tissue fibrosis expressed by myofibroblasts and their progenitors...
Main Authors: | Kauffman, Kevin John, Mir, Faryal, Anderson, Daniel Griffith |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemical Engineering |
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2019
|
Online Access: | https://hdl.handle.net/1721.1/121997 |
Similar Items
-
Lipid-Modified Aminoglycoside Derivatives for In Vivo siRNA Delivery
by: Zhang, Yunlong, et al.
Published: (2014) -
Substrate architecture effect on siRNA silencing.
by: Koh, Hwee Ciah.
Published: (2009) -
Development of siRNA-probes for studying intracellular trafficking of siRNA nanoparticles
by: Alabi, Christopher A., et al.
Published: (2014) -
FRET-Labeled siRNA Probes for Tracking Assembly and Disassembly of siRNA-Nanocomplexes
by: Alabi, Christopher A., et al.
Published: (2013) -
Nanocarriers for delivery of siRNA as gene silencing mediator
by: Aideé Morales-Becerril, et al.
Published: (2022-08-01)